🌟 Call for attendees to the CRISPRMED26 Workshops! 🌟
Dear GenE-HumDi Members,
We support early career and young researchers in the field of therapeutic Gene Editing. For this reason, we are very excited to announce that we will be supporting selected young members attending the CRISPRMED26 Conference and enrolled in the CRISPRMED26 Workshops, co-organized by GenE-HumDi (COST action CA21113) and CRISPR MEDICINE NEWS (CRISPRMED) as part of the CRISPRMED’26 conference.
The CRISPRMED26 workshops offer students an interactive opportunity to acquire critical applied knowledge and skills that will expand their profile in the gene-editing field. With a limited number of 30 places per workshop, we focus on delivering high-quality, interactive workshops in which you can learn by doing instead of just listening.
🗺️ When and where?
The CRISPRMED26 workshops will be held from 9:00-13:30 CEST on the 14th April 2026.
Each workshop will last 1 hour and 25 minutes.
Workshop facilitators: TBD
📚 Workshop Topics:
Tools: Choosing the Right Gene-Editing Approach
This workshop will be faciliated by: TBD
The workshop will start with an introduction to various genome-editing technologies highlighting their mechanisms, advantages, and limitations.
We will also discuss recent developments in genome-editing tools, focusing on those DSB-free and with demonstrated therapeutic potential, such as base- and prime editing. Next, we will cover criteria for selecting the appropriate genome-editing tool based on the targeted disease and present case studies of therapeutic applications.
We will emphasise that different diseases require distinct genome-editing strategies depending on the aim, such as gene replacement, gene restoration, or gene insertion.
The workshop will include a hands-on session with practical demonstrations and group activities to design genome-editing experiments. Finally, we will address ethical and safety considerations, emphasising regulatory guidelines and best practices.
The workshop will be highly interactive, with Q&A sessions throughout, pausing at key points for discussion.
- Dr. Claudio Mussolino, (Universitaetsklinikum Freiburg. Germany)
- Dr. Raúl Perez-Jimenez, (Ikerbasque Research Professor. Spain)
- Dr. Antonio Carusillo, (Università di Modena e Reggio Emilia. Italy)
Delivery: Navigating the CRISPR Delivery Landscape
This workshop will be faciliated by: TBD
This workshop will focus on navigating the current landscape of viral- and non-viral delivery methods for CRISPR gene-editing tools.
The session will provide the participants a broad and comparative introduction on the various delivery methods available for the different CRSPR gene-editing tools, their advantages and disadvantages.
Importantly, the workshop will try to achieve a comprehensive understanding on how to select the right delivery tool for a specific CRISPR gene editing in cells to achieve high efficacy, the so-called “CRISPR-Delivery-Cell, CDC” match-making procedure.
- Dr. Juan Antonio Marchal, (University of Granada.Spain)
- Dr. André Görgens, (Karolinska Institutet | Department of Laboratory Medicine, Division of Biomolecular and Cellular Medicine. Sweden)
Safety: Pre-clinical Safety Analyses
This workshop will be faciliated by: TBD.
This workshop will focus on the side effects derived from the use of genome editors. The session will address the risks associated with the unspecific activity of CRISPR-based platforms, which can impact both the safety and efficacy of gene-editing approaches. Participants will gain a comprehensive understanding of the different types of potential genotoxic events and of the different methods available to monitor unintended genomic modifications, including those aligned with regulatory guidelines:
– Off-target activity of genome editors
– Genotoxicity: on- and off-target aberrations
– Off-target evaluation methods
– Mitigation strategies
– Hands-on basic training on specificity prediction
Dr. Ciaran Lee PhD (University College Cork. Ireland)
💶 Gene-HumdI TRAVEL GRANTS COVER:
- Long-distance travel support to/from the venue*
- Daily allowance for the workshop*
*Long-distance travel expenses up to 500.00€ and daily allowance will be reimbursed according to the approved budget and will abide by current COST annotated rules.
📝 How to Apply:
Interested attendees must apply soon:
- Send an email to the Grant Holder Manager (raquel.soriano@juntadeandalucia.es) indicating the state of your application for the workshop, application abstract ( if submited) and providing your chosen topic.
- Note: Registration to this workshop is free but has to be done within the CRISPR MED WORKSHOP RESGISTRATION form.
- Include in the email a letter of interest, of no more than 1,000 words addressed to the Grant Award Coordinator. Please include:
- A contact e-mail address if different from your COST contact.
- Your current position
- Whether you are an active member in any GeneHumdi WG.
- List your contributions to GeneHumdi initiatives (meetings, white papers, peer-reviewed papers, etc, …)
- How does your work/research/interest align with the workshop topics?
- How attending will benefit their current position or future perspectives?
📅 Deadline:
Applications will be considered from January 28th and no later than
February 20th!
This date is needed to allow the timely resolution and communication of grants.
The budget is limited and active young members not previously selected for funded participation in GeneHumdi calls will be given priority. Like, oral communication already accepted by the CRISPR MEDICINE 26 conference will be positively considered during the application evaluation.
The Grant Award Coordinator will ensure fair review of all applications and shortlisted applicants are expected to receive feedback by the second week of March.
📚 Call Documentation:
Don’t miss this opportunity to enhance your knowledge and network with experts in the field!
For questions or to submit your application, contact the Grant Holder Manager at raquel.soriano@juntadeandalucia.es.
We look forward to your applications!
Best regards,
The GenE-HumDi Team
Granada, January 28th 2026
